Cargando…

The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study

Glomerular filtration (GF) and active tubular secretion (ATS) contribute to renal drug elimination, with the latter remaining understudied across the pediatric age range. Therefore, we systematically analyzed the influence of transporter ontogeny on the relative contribution of GF and ATS to renal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristea, Sînziana, Krekels, Elke Henriëtte Josephina, Rostami-Hodjegan, Amin, Allegaert, Karel, Knibbe, Catherijne Annette Jantine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306484/
https://www.ncbi.nlm.nih.gov/pubmed/32566984
http://dx.doi.org/10.1208/s12248-020-00468-7
_version_ 1783548662136176640
author Cristea, Sînziana
Krekels, Elke Henriëtte Josephina
Rostami-Hodjegan, Amin
Allegaert, Karel
Knibbe, Catherijne Annette Jantine
author_facet Cristea, Sînziana
Krekels, Elke Henriëtte Josephina
Rostami-Hodjegan, Amin
Allegaert, Karel
Knibbe, Catherijne Annette Jantine
author_sort Cristea, Sînziana
collection PubMed
description Glomerular filtration (GF) and active tubular secretion (ATS) contribute to renal drug elimination, with the latter remaining understudied across the pediatric age range. Therefore, we systematically analyzed the influence of transporter ontogeny on the relative contribution of GF and ATS to renal clearance CL(R) for drugs with different properties in children. A physiology-based model for CL(R) in adults was extrapolated to the pediatric population by including maturation functions for the system-specific parameters. This model was used to predict GF and ATS for hypothetical drugs with a range of drug-specific properties, including transporter-mediated intrinsic clearance (CL(int,T)) values, that are substrates for renal secretion transporters with different ontogeny patterns. To assess the impact of transporter ontogeny on ATS and total CL(R), a percentage prediction difference (%PD) was calculated between the predicted CL(R) in the presence and absence of transporter ontogeny. The contribution of ATS to CL(R) ranges between 41 and 90% in children depending on fraction unbound and CL(int,T) values. If ontogeny of renal transporters is < 0.2 of adult values, CL(R) predictions are unacceptable (%PD > 50%) for the majority of drugs regardless of the pediatric age. Ignoring ontogeny patterns of secretion transporters increasing with age in children younger than 2 years results in CL(R) predictions that are not systematically acceptable for all hypothetical drugs (%PD > 50% for some drugs). This analysis identified for what drug-specific properties and at what ages the contribution of ATS on total pediatric CL(R) cannot be ignored. Drugs with these properties may be sensitive in vivo probes to investigate transporter ontogeny. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1208/s12248-020-00468-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7306484
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73064842020-06-22 The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study Cristea, Sînziana Krekels, Elke Henriëtte Josephina Rostami-Hodjegan, Amin Allegaert, Karel Knibbe, Catherijne Annette Jantine AAPS J Research Article Glomerular filtration (GF) and active tubular secretion (ATS) contribute to renal drug elimination, with the latter remaining understudied across the pediatric age range. Therefore, we systematically analyzed the influence of transporter ontogeny on the relative contribution of GF and ATS to renal clearance CL(R) for drugs with different properties in children. A physiology-based model for CL(R) in adults was extrapolated to the pediatric population by including maturation functions for the system-specific parameters. This model was used to predict GF and ATS for hypothetical drugs with a range of drug-specific properties, including transporter-mediated intrinsic clearance (CL(int,T)) values, that are substrates for renal secretion transporters with different ontogeny patterns. To assess the impact of transporter ontogeny on ATS and total CL(R), a percentage prediction difference (%PD) was calculated between the predicted CL(R) in the presence and absence of transporter ontogeny. The contribution of ATS to CL(R) ranges between 41 and 90% in children depending on fraction unbound and CL(int,T) values. If ontogeny of renal transporters is < 0.2 of adult values, CL(R) predictions are unacceptable (%PD > 50%) for the majority of drugs regardless of the pediatric age. Ignoring ontogeny patterns of secretion transporters increasing with age in children younger than 2 years results in CL(R) predictions that are not systematically acceptable for all hypothetical drugs (%PD > 50% for some drugs). This analysis identified for what drug-specific properties and at what ages the contribution of ATS on total pediatric CL(R) cannot be ignored. Drugs with these properties may be sensitive in vivo probes to investigate transporter ontogeny. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1208/s12248-020-00468-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-06-21 /pmc/articles/PMC7306484/ /pubmed/32566984 http://dx.doi.org/10.1208/s12248-020-00468-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Cristea, Sînziana
Krekels, Elke Henriëtte Josephina
Rostami-Hodjegan, Amin
Allegaert, Karel
Knibbe, Catherijne Annette Jantine
The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title_full The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title_fullStr The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title_full_unstemmed The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title_short The Influence of Drug Properties and Ontogeny of Transporters on Pediatric Renal Clearance through Glomerular Filtration and Active Secretion: a Simulation-Based Study
title_sort influence of drug properties and ontogeny of transporters on pediatric renal clearance through glomerular filtration and active secretion: a simulation-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306484/
https://www.ncbi.nlm.nih.gov/pubmed/32566984
http://dx.doi.org/10.1208/s12248-020-00468-7
work_keys_str_mv AT cristeasinziana theinfluenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT krekelselkehenriettejosephina theinfluenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT rostamihodjeganamin theinfluenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT allegaertkarel theinfluenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT knibbecatherijneannettejantine theinfluenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT cristeasinziana influenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT krekelselkehenriettejosephina influenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT rostamihodjeganamin influenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT allegaertkarel influenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy
AT knibbecatherijneannettejantine influenceofdrugpropertiesandontogenyoftransportersonpediatricrenalclearancethroughglomerularfiltrationandactivesecretionasimulationbasedstudy